Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Improving Substance Abuse Counseling Adherence Using Web-based Videoconferencing

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Van King, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT01142609
First received: June 10, 2010
Last updated: April 2, 2013
Last verified: April 2013
  Purpose

This research is being done to compare the effectiveness of standard on-site, in-person counseling with Internet web-based videoconferencing (e-therapy) in drug-dependent patients in opioid-agonist treatment programs. The study is looking to see if there are any differences in satisfaction or in treatment outcome if counseling sessions are given by e-therapy compared to standard, in-person counseling given in the clinic. The e-therapy happens in real time- it works very much like standard therapy in the clinic except that the patient is in his or her own home (or other convenient location outside the clinic) and talks to and sees the therapist through an Internet connection on the computer (the therapist will usually be at the clinic).


Condition Intervention
Substance Abuse Disorder
Behavioral: eGet

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Improving Substance Abuse Counseling Adherence Using Web-based Videoconferencing

Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:
  • Counseling efficacy [ Time Frame: Weekly for 12 weeks ] [ Designated as safety issue: No ]
    Attendance to individual counseling sessions, both online and on-site will be tracked weekly for the duration of the study.

  • Reinforcement value (eGetgoing) [ Time Frame: Monthly for 3 months ] [ Designated as safety issue: No ]
    Subjects will complete monthly surveys to evaluate the reinforcement value of eGetgoing using a multiple choice design that will compare its perceived value to other aspects of routine treatment (e.g., take-home medications).

  • Reinforcement value (on-site) [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Subjects will complete a survey to evaluate the reinforcement value of eGetgoing using a multiple choice design that will compare its perceived value to other aspects of routine treatment (e.g., take-home medications).


Secondary Outcome Measures:
  • Program Satisfaction [ Time Frame: Baseline and monthly for 3 months ] [ Designated as safety issue: No ]
    Subjects will complete a survey to assess their overall program satisfaction

  • Treatment cost [ Time Frame: Baseline and Month 3 ] [ Designated as safety issue: No ]
    Subjects will complete surveys to measure treatment related time and monetary travel costs.

  • Therapeutic relationship [ Time Frame: Baseline and monthly for 3 months ] [ Designated as safety issue: No ]
    Subjects and their therapists will complete surveys to assess qualities of the therapeutic relationship.


Enrollment: 85
Study Start Date: December 2009
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Internet (eGetgoing)
Subjects will assigned to use an accredited web-based platform (eGetgoingTM, CRC Health Group, Inc.) to deliver routine substance abuse counseling.
Behavioral: eGet
eGet individual counseling sessions from home will be scheduled weekly for 12 weeks.
No Intervention: Routine on-site
Subjects will attend routine face-to-face individual counseling sessions.

Detailed Description:

This study will be the first to evaluate the efficacy of an accredited and currently available, Internet web-based videoconferencing platform to deliver routine schedules of counseling in an opioid agonist treatment program. It has outstanding potential to help determine transportability of this technology to other treatment programs by demonstrating the benefits of integration of web-based therapy with on-site services to expand the continuum of care.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Access to a computer with Internet capability
  • Full adherence to their routine counseling schedule over the previous 30-days
  • Negative urine specimens over the previous 30-days
  • Patient at ATS for 90 days

Exclusion Criteria:

  • No access to a computer with Internet capability
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01142609

Locations
United States, Maryland
Addiction Treatment Services
Baltimore, Maryland, United States, 21224
Sponsors and Collaborators
Johns Hopkins University
Investigators
Principal Investigator: Van King, M.D. Johns Hopkins University
  More Information

No publications provided

Responsible Party: Van King, Associate Professor, Johns Hopkins University
ClinicalTrials.gov Identifier: NCT01142609     History of Changes
Other Study ID Numbers: 1RC1DA028189-01, 1RC1DA028189-01
Study First Received: June 10, 2010
Last Updated: April 2, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Johns Hopkins University:
Web based videoconferencing
methadone
substance abuse counseling

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on November 25, 2014